Loading organizations...
Cardiology and endovascular devices for cardiologists and hospitals, treating vascular diseases with guidewires, stents, and drug-eluting stents.
Cordis is a medical device manufacturer based in Miami Lakes, Florida, that develops and provides cardiology and endovascular technologies, including guidewires and drug-eluting stents, for the treatment of vascular diseases. The organization supplies its specialized cardiovascular products directly to hospitals, cardiologists, and endovascular specialists globally, maintaining a broad international footprint that includes an Asia-Pacific headquarters located in Singapore. Previously owned by major corporate entities Johnson & Johnson and Cardinal Health, the medical business was subsequently acquired by private equity firm Hellman & Friedman during a 2021 transaction. Under the current leadership of Chief Executive Officer Scott Drake, the enterprise continuously drives new product development through internal research, strategic acquisitions, and its dedicated Cordis-X partnership model to improve clinical outcomes. Cordis was originally founded as Medical Development Corp. in 1957 by Dr. William Murphy.
Cordis has raised $8.0M across 1 funding round.
Key people at Cordis.
Cordis was founded by William P. Murphy Jr. (Founder).
Cordis has raised $8.0M in total across 1 funding round.
Key people at Cordis.
Cordis was founded by William P. Murphy Jr. (Founder).
Cordis has raised $8.0M in total across 1 funding round.
Cordis has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2023 | Puzzle Medical Devices | $25.0M Series A | Cordis-X | Broadview Ventures, SOSV, Duke Rohlen, BDC Capital, Desjardins Capital, Hellman & Friedman, KKR, Longview Ventures |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 26, 2025 | $8.0M Seed |
